Therefore, treatment with the combination of IL-2 and a calcineurin inhibitor can induce Treg expansion while inhibiting the expansion of inflammatory cytokine-producing CD4+ T cells, resulting in an additive effect in experimental autoimmune encephalomyelitis (32). This evidence concerns the gene CD4 and experimental autoimmune encephalomyelitis.